hiv delivery

A report filed by Dr. Bishwajit Kundu indicated that SARS-CoV-2 was not only man made, but utilized the HIV delivery system for infectivity. 

This study was filed in January of 2020 at the start of the outbreak, and has since been withdrawn by the publishing organization BioRxiv.  The reason for the withdraw is that the study had not been validated by peer review, which is the same argument used against the study put out by Chinese virologist Dr. Yan.

The report, embedded below, indicates that the virus was engineered and had an “uncanny similarity of novel inserts in the 2019-nCoVspike protein to HIV-1 gp120 and Gag.”

The peculiar aspect of this is the development of the Johnson & Johnson vaccine.  As reported by the New York Times, the vaccine developed by manipulating existing Ad26 vaccines.  They reported:

In March, Dr. Barouch and his colleagues designed seven variants of an Ad26 vaccine for the coronavirus. They made tiny changes to the spike gene to see whether they could get cells to make more copies of the viral protein. They also tested variants that would make the spike protein more stable, which might prompt a stronger immune response.

The reason that this is important is that the Ad26 vaccine was developed in order to treat HIV. 

The National Institute of Health (NIH) reported in 2017:

The experimental vaccine regimens evaluated in APPROACH are based on “mosaic” vaccines designed to induce immunological responses against a wide variety of HIV subtypes responsible for HIV infections globally. Different HIV subtypes, or clades, predominate in various geographic regions around the world. The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, funded pre-clinical development of these vaccines. Together with other partners, NIAID supported the APPROACH trial, which is sponsored by Janssen Vaccines & Prevention B.V., part of the Janssen Pharmaceutical Companies of Johnson & Johnson. The manufacture and clinical development of the mosaic vaccines are led by Janssen.

That’s correct.  Johnson & Johnson created the experimental HIV vaccine that is now in late stage testing for use against SARS-CoV-2.

To be clear, I am not a virologist, but find this to be highly suspect, and that a genetic insertion of the HIV delivery system would make perfect sense.

By Josh Earwood

Josh has been an activist, citizen journalist, and commentator since 2013. He spent two years as a broadcast journalist, and has written for various groups in various capacities over the years. He has always been vocal, encouraging others to understand what is going on in the world around them.

Leave a Reply

Your email address will not be published. Required fields are marked *